Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promoter Methylation of <i>CDO1</i> Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome

22 Apr 2015

Abstract excerpt

PURPOSE: In this era of molecular diagnostics, prediction of clear-cell renal cell cancer (ccRCC) survival requires optimization, as current prognostic markers fail to determine individual patient outcome. Epigenetic events are promising molecular markers. Promoter CpG island methylation of cysteine dioxygenase type 1 (CDO1), which was identified as prognostic marker for breast cancer, is studied as a potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25904753
DOI: 10.1158/1078-0432.ccr-14-2049

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promoter Methylation of <i>CDO1</i> Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival OutcomePMID 25904753Read ↗

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markersSemantic proximity Read ↗

CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patientsSemantic proximity Read ↗

A CpG-methylation-based assay to predict survival in clear cell renal cell carcinomaSemantic proximity Read ↗

Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinomaSemantic proximity Read ↗

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer PatientsSemantic proximity Read ↗

The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic TreatmentsSemantic proximity Read ↗

High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinomaSemantic proximity Read ↗

DNA methylation expression patterns predict outcome of clear cell renal cell carcinomaSemantic proximity Read ↗

CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer PatientsSemantic proximity Read ↗

Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes.Semantic proximity Read ↗

Prognostic and immune correlation of IDO1 promoter methylation in breast cancerSemantic proximity Read ↗

MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samplesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.